2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines

Annals of Thoracic Surgery

Volumn 91, Issue 3, 2011, Pages 944-982

  Ferraris, Victor A ^a   Brown, Jeremiah R ^g   Despotis, George J ^f   Hammon, John W ^h   Reece, T Brett ⁿ   Saha, Sibu P ^a   Song, Howard K ^m   Clough, Ellen R ^p   Shore Lesserson, Linda J ^e   Goodnough, Lawrence T ^d   Mazer, C David ⁱ   Shander, Aryeh ^c   Stafford Smith, Mark ^o   Waters, Jonathan ^b   Baker, Robert A ^j   Dickinson, Timothy A ^k   Fitzgerald, Daniel J ^l   Likosky, Donald S ^g   Shann, Kenneth G ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j FLINDERS MEDICAL CENTRE   (Australia)

^k Specialty Care Inc   (United States)

^l HARVARD UNIVERSITY   (United States)

^m OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁿ UNIVERSITY OF COLORADO   (United States)

^o DUKE UNIVERSITY MEDICAL CENTER   (United States)

^p Society of Thoracic Surgeons   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTITHROMBIN III; APROTININ; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; CLOPIDOGREL; ERYTHROPOIETIN; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; HEPARIN; IRON; LYSINE DERIVATIVE; PRASUGREL; PROTHROMBIN COMPLEX; PURINERGIC P2Y12 RECEPTOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ANESTHESIST; AORTA GRAFT; ARTICLE; BLEEDING; BLOOD CONSERVATION; BLOOD SALVAGE; BLOOD TRANSFUSION; CARDIOPLEGIA; CARDIOVASCULAR SURGERY; CATHETERIZATION; CENTRIFUGATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DEATH; ERYTHROCYTE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEART FAILURE; HEART PRESERVATION; HEART SURGERY; HEMATOCRIT; HUMAN; KIDNEY FAILURE; LUNG PERFUSION; LUNG VENTILATION PERFUSION RATIO; MEDLINE; MINIMALLY INVASIVE PROCEDURE; OFF PUMP CORONARY SURGERY; OXYGENATION; PLASMA TRANSFUSION; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE; THORAX SURGERY; THROMBOCYTOPHERESIS; ULTRAFILTRATION; VASCULAR DISEASE;

ANESTHESIOLOGY; BLOOD PRESERVATION; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; THORACIC SURGERY;

EID: 79951972309     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.11.078     Document Type: Article

References (404)

1. M.T. Sullivan, R. Cotten, E.J. Read, and E.L. Wallace Blood collection and transfusion in the United States in 2001 Transfusion 47 2007 385 394
2. B.D. Spiess Blood transfusion: the silent epidemic Ann Thorac Surg 72 Suppl 2001 1832 1837
3. R. Ascione, S. Williams, and C.T. Lloyd Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study J Thorac Cardiovasc Surg 121 2001 689 696
4. R.H. Mehta, S. Sheng, and S.M. O'Brien Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends and outcomes Circ Cardiovasc Qual Outcomes 2 2009 583 590
5. C.T. Mora Mangano, M.J. Neville, and P.H. Hsu Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest Circulation 104 2001 I276 I281
6. E.A. Genovese, M.A. Dew, and J.J. Teuteberg Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation Ann Thorac Surg 88 2009 1162 1170
7. M.C. Engoren, R.H. Habib, and A. Zacharias Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 74 2002 1180 1186 (Pubitemid 35176743)
8. C.G. Koch, L. Li, and D.I. Sessler Duration of red-cell storage and complications after cardiac surgery N Engl J Med 358 2008 1229 1239 (Pubitemid 351439224)
9. V.A. Ferraris, S.P. Ferraris, and S.P. Saha Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 83 Suppl 2007 27 86
10. L.H. Edmunds, and R.W. Colman Thrombin during cardiopulmonary bypass Ann Thorac Surg 82 2006 2315 2322 (Pubitemid 44794379)
11. A.L. Shroyer, F.L. Grover, and B. Hattler On-pump versus off-pump coronary-artery bypass surgery N Engl J Med 361 2009 1827 1837
12. L.H. Edmunds, and R.W. Colman Bleeding that won't stop Ann Thorac Surg 85 2008 1153 1154 (Pubitemid 351381709)
13. J.S. Berger, C.B. Frye, and Q. Harshaw Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol 52 2008 1693 1701
14. E. Mahla, H. Metzler, U.S. Tantry, and P. Gurbel Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery Ann Thorac Surg 90 2010 1040 1051
15. A.A. Haydar, A.B. Abchee, and H. El Bleeding post coronary artery bypass surgery Clopidogrelcure or culprit? J Med Liban 54 2006 11 16 (Pubitemid 44606282)
16. G.N. Vaccarino, J. Thierer, and M. Albertal Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis J Thorac Cardiovasc Surg 137 2009 309 313
17. R. Ebrahimi, C. Dyke, and R. Mehran Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 53 2009 1965 1972
18. S. Maltais, L.P. Perrault, and Q.B. Do Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery Eur J Cardiothorac Surg 34 2008 127 131
19. R.H. Mehta, M.T. Roe, and J. Mulgund Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery J Am Coll Cardiol 48 2006 281 286
20. T. Wolff, T. Miller, and S. Ko Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 150 2009 405 410
21. U.S. Preventive Services Task Force Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 150 2009 396 404
22. V.A. Ferraris, S.P. Ferraris, and D.J. Moliterno The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary) Ann Thorac Surg 79 2005 1454 1461 (Pubitemid 40431898)
23. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
24. G. Montalescot, S.D. Wiviott, and E. Braunwald Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
25. R. Marcucci, A.M. Gori, and R. Paniccia Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
26. S. Guha, P. Sardar, and P. Guha Dual antiplatelet drug resistance in patients with acute coronary syndrome Indian Heart J 61 2009 68 73
27. D.J. Angiolillo, S. Suryadevara, and P. Capranzano Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists Catheter Cardiovasc Interv 73 2009 1 14
28. D.J. Kereiakes, and P.A. Gurbel Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention J Am Coll Cardiol Intv 1 2008 111 121 (Pubitemid 351506557)
29. G. Feher, A. Feher, and G. Pusch The genetics of antiplatelet drug resistance Clin Genet 75 2009 1 18
30. P. Gladding, M. Webster, and I. Zeng The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial J Am Coll Cardiol Intv 1 2008 620 627
31. E. Shantsila, and G.Y. Lip "Aspirin resistance" or treatment non-compliance: which is to blame for cardiovascular complications? J Transl Med 6 2008 47
32. T. Gremmel, S. Steiner, and D. Seidinger Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation Thromb Haemost 101 2009 333 339
33. J.H. Oestreich, S.S. Smyth, and C.L. Campbell Platelet function analysis: at the edge of meaning Thromb Haemost 101 2009 217 219
34. N.J. Breet, J.W. van Werkum, and H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
35. L. Bonello, L. Camoin-Jau, and S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411 (Pubitemid 351447314)
36. J.H. Patel, J.A. Stoner, A. Owora, S.T. Mathew, and U. Thadani Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients Am J Cardiol 103 2009 1687 1693
37. S. Bevilacqua, A.A. Alkodami, and E. Volpi Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function Ann Thorac Surg 87 2009 496 502
38. Manufacturer removes remaining stocks of trasylol: access limited to investigational use 2008 U. S. Food and Drug Administration
39. R.E. Helm, J.P. Gold, and T.K. Rosengart Erythropoietin in cardiac surgery J Card Surg 8 1993 579 606 (Pubitemid 23300117)
40. M.G. Vitale, E.J. Stazzone, A.C. Gelijns, A.J. Moskowitz, and D.P. Roye The effectiveness of preoperative erythropoietin in averting allogenic blood transfusion among children undergoing scoliosis surgery J Pediatr Orthop B 7 1998 203 209 (Pubitemid 28365718)
41. T.G. Monk Preoperative recombinant human erythropoietin in anemic surgical patients Crit Care 8 Suppl 2 2004 45 48
42. M.A. Goldberg Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials Semin Hematol 34 1997 41 47 (Pubitemid 27319144)
43. J.F. Hardy Pharmacological strategies for blood conservation in cardiac surgery: erythropoietin and antifibrinolytics Can J Anaesth 48 Suppl 2001 24 31
44. A.A. Alghamdi, M.J. Albanna, V. Guru, and S.J. Brister Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis J Card Surg 21 2006 320 326
45. S.N. Madi-Jebara, G.S. Sleilaty, and P.E. Achouh Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery J Cardiothorac Vasc Anesth 18 2004 59 63 (Pubitemid 38240762)
46. M. Osaka, I. Fukuda, and H. Ohuchi Aprotinin and recombinant human erythropoietin reduce the need for homologous blood transfusion in cardiac surgery Jpn J Thorac Cardiovasc Surg 46 1998 846 853
47. Y. Yoshikawa, K. Niwaya, and J. Hasegawa Effect of blood conservation in open-heart surgery: a comparison of 3 different methods Kyobu Geka 47 1994 1059 1062
48. S. Price, J.R. Pepper, and S.I. Jaggar Recombinant human erythropoietin use in a critically ill Jehovah's witness after cardiac surgery Anesth Analges 101 2005 325 327 table of contents (Pubitemid 41045205)
49. V. Sonzogni, G. Crupi, and R. Poma Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery Br J Anaesth 87 2001 429 434 (Pubitemid 32827479)
50. H. Shimpo, T. Mizumoto, K. Onoda, H. Yuasa, and I. Yada Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose Chest 111 1997 1565 1570 (Pubitemid 27260084)
51. O. Sowade, H. Warnke, and P. Scigalla Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery Blood 89 1997 411 418 (Pubitemid 27051675)
52. T.K. Rosengart, R.E. Helm, J. Klemperer, K.H. Krieger, and O.W. Isom Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses Ann Thorac Surg 58 1994 1397 1403 (Pubitemid 24347532)
53. D.A. Fullerton, D.N. Campbell, and G.J. Whitman Use of human recombinant erythropoietin to correct severe preoperative anemia Ann Thorac Surg 51 1991 825 826
54. V.A. Gaudiani, and H.D. Mason Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures Ann Thorac Surg 51 1991 823 824
55. M.A. Hoynck van Papendrecht, H. Jeekel, O.R. Busch, and R.L. Marquet Efficacy of recombinant erythropoietin for stimulating erythropoiesis after blood loss and surgery An experimental study in rats Eur J Surg 158 1992 83 87
56. S. Beholz, J. Liu, R. Thoelke, C. Spiess, and W. Konertz Use of desmopressin and erythropoietin in an anaemic Jehovah's Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement Perfusion 16 2001 485 489 (Pubitemid 33094564)
57. I. Yamagishi, T. Sakurada, and T. Abe Cardiac surgery using only autologous blood for a patient with hereditary spherocytosis: a case report Ann Thorac Cardiovasc Surg 4 1998 294 297
58. B.D. Spiess Transfusion of blood products affects outcome in cardiac surgery Semin Cardiothorac Vasc Anesth 8 2004 267 281 (Pubitemid 39603175)
59. L. Weltert, S. D'Alessandro, and S. Nardella Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study J Thorac Cardiovasc Surg 139 2010 621 627
60. J.W. Fisher Pharmacologic modulation of erythropoietin production Annu Rev Pharmacol Toxicol 28 1988 101 122
61. W.S. Beattie, D.N. Wijeysundera, and K. Karkouti Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study Anesthesiology 112 2010 25 33
62. R.T. Means Clinical application of recombinant erythropoietin in the anemia of chronic disease Hematol Oncol Clin North Am 8 1994 933 944
63. J.R. Brown, N.J. Birkmeyer, and G.T. O'Connor Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery Circulation 115 2007 2801 2813 (Pubitemid 46876483)
64. J.R. Brown, N.J.O. Birkmeyer, and G.T. O'Connor Aprotinin in cardiac surgery N Engl J Med 354 2006 1953 1957
65. D.A. Fergusson, P.C. Hebert, and C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331 (Pubitemid 351749156)
66. D. Henry, P. Carless, D. Fergusson, and A. Laupacis The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis Can Med Assoc J 180 2009 183 193
67. K. Karkouti, W.S. Beattie, and K.M. Dattilo A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion- risk cardiac surgery Transfusion 46 2006 327 338 (Pubitemid 43334084)
68. D.T. Mangano, Y. Miao, and A. Vuylsteke Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery JAMA 297 2007 471 479
69. D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365 (Pubitemid 43145060)
70. P.C. Holland Statistical review of the observational studies of aprotinin safety part II: The i3 Drug Safety Study CRDAC and DSaRM Meeting 2007 U. S. Food and Drug Administration
71. Z.Y. Strouch, M.L. Drum, and M.A. Chaney Aprotinin use during cardiac surgery: recent alterations and effects on blood product utilization J Clin Anesth 21 2009 502 507
72. X. Wang, Z. Zheng, and H. Ao A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China J Thorac Cardiovasc Surg 138 2009 897 903
73. M. Kluth, J.U. Lueth, and A. Zittermann Safety of low-dose aprotinin in coronary artery bypass graft surgery: a single-centre investigation in 2,436 patients in Germany Drug Saf 31 2008 617 626 (Pubitemid 351861954)
74. C. Murugesan, S.K. Banakal, R. Garg, S. Keshavamurthy, and K. Muralidhar The efficacy of aprotinin in arterial switch operations in infants Anesth Analges 107 2008 783 787
75. A. Manrique, E.H. Jooste, and B.A. Kuch The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass Anesth Analges 109 2009 45 52
76. K. Karkouti, D.N. Wijeysundera, and T.M. Yau The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery Anesth Analges 110 2010 21 29
77. H. Takagi, H. Manabe, N. Kawai, S.N. Goto, and T. Umemoto Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials Interact Cardiovasc Thorac Surg 9 2009 98 101
78. B.J. Kober, A.M. Scheule, and V. Voth Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant Anesth Analges 107 2008 406 409
79. K. Martin, G. Wiesner, T. Breuer, R. Lange, and P. Tassani The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients Anesth Analges 107 2008 1783 1790
80. A.T. Santos, R.A. Kalil, C. Bauemann, J.B. Pereira, and I.A. Nesralla A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting Braz J Med Biol Res 39 2006 63 69 (Pubitemid 43091529)
81. P.S. Myles, J. Smith, and J. Knight Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial: rationale and design Am Heart J 155 2008 224 230
82. R. Taneja, P. Fernandes, G. Marwaha, D. Cheng, and D. Bainbridge Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian survey J Cardiothorac Vasc Anesth 22 2008 662 669
83. S.A. Snyder-Ramos, P. Mohnle, and Y.S. Weng The ongoing variability in blood transfusion practices in cardiac surgery Transfusion 48 2008 1284 1299
84. D. De Backer, B. Vandekerckhove, and S. Stanworth Guidelines for the use of fresh frozen plasma Acta Clin Belg 63 2008 381 390
85. D.F. O'Shaughnessy, C. Atterbury, and P. Bolton Maggs Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant Br J Haematol 126 2004 11 28 (Pubitemid 38859478)
86. Medical Directors Advisory Committee, National Blood Transfusion Council Guideline for the use of fresh-frozen plasma S Afr Med J 88 1998 1344 1347
87. S.J. Stanworth, C.J. Hyde, and M.F. Murphy Evidence for indications of fresh frozen plasma Transfus Clin Biol 14 2007 551 556
88. L.T. Goodnough, and G.J. Despotis Transfusion medicine: support of patients undergoing cardiac surgery Am J Cardiovasc Drugs 1 2001 337 351
89. J. Ansell, J. Hirsh, and E. Hylek Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 Suppl 2008 160 198
90. J.D. Douketis, P.B. Berger, and A.S. Dunn The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 Suppl 2008 299 339
91. I. Pabinger-Fasching Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate Thromb Res 122 Suppl 2 2008 19 22
92. D. Bruce, and T.J. Nokes Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital Crit Care 12 2008 R105
93. B.E. Ickx, and A. Steib Perioperative management of patients receiving vitamin K antagonists Can J Anaesth 53 Suppl 2006 113 122
94. C.A. Leissinger, P.M. Blatt, W.K. Hoots, and B. Ewenstein Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature Am J Hematol 83 2008 137 143
95. L. Holland, T.E. Warkentin, and M. Refaai Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Transfusion 49 2009 1171 1177
96. B.D. Spiess Treating heparin resistance with antithrombin or fresh frozen plasma Ann Thorac Surg 85 2008 2153 2160 (Pubitemid 351685591)
97. P.G. Teixeira, K. Inaba, and I. Shulman Impact of plasma transfusion in massively transfused trauma patients J Trauma 66 2009 693 697
98. C.W. Snyder, J.A. Weinberg, and G. McGwin The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 66 2009 358 364
99. T.M. Scalea, K.M. Bochicchio, and K. Lumpkins Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients Ann Surg 248 2008 578 584
100. P.I. Johansson, and J. Stensballe Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study Vox Sang 96 2009 111 118
101. A.C. Casbard, L.M. Williamson, M.F. Murphy, K. Rege, and T. Johnson The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery A systematic review Anaesthesia 59 2004 550 558 (Pubitemid 38744889)
102. S.J. Stanworth, S.J. Brunskill, C.J. Hyde, D.B. McClelland, and M.F. Murphy Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials Br J Haematol 126 2004 139 152 (Pubitemid 38859495)
103. E.C. Consten, C.P. Henny, L. Eijsman, D.A. Dongelmans, and M.H. van Oers The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified J Thorac Cardiovasc Surg 112 1996 162 167 (Pubitemid 26268983)
104. S.M. Kasper, T. Giesecke, and P. Limpers Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery Anesthesiology 95 2001 81 86 discussion 86A (Pubitemid 32623000)
105. M. Wilhelmi, U. Franke, and T. Cohnert Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible? Eur J Cardiothorac Surg 19 2001 657 661 (Pubitemid 32416616)
106. R. Colman, V. Marder, A. Clowes, J. George, and S. Goldharber Hemostasis and thrombosis 5th ed. 2006 Lippincott Williams & Wilkins Philadelphia
107. W.L. Chandler, M.A. Patel, and L. Gravelle Factor XIIIA and clot strength after cardiopulmonary bypass Blood Coagul Fibrinolysis 12 2001 101 108 (Pubitemid 32234817)
108. O. Godje, U. Gallmeier, M. Schelian, M. Grunewald, and H. Mair Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation Thorac Cardiovasc Surg 54 2006 26 33 (Pubitemid 43232140)
109. O. Godje, M. Haushofer, P. Lamm, and B. Reichart The effect of factor XIII on bleeding in coronary surgery Thorac Cardiovasc Surg 46 1998 263 267 (Pubitemid 28562035)
110. R. Gerlach, F. Tolle, and A. Raabe Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study Stroke 33 2002 1618 1623 (Pubitemid 34619968)
111. J.R. Shainoff, F.G. Estafanous, and J.P. Yared Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting J Thorac Cardiovasc Surg 108 1994 437 445 (Pubitemid 24299668)
112. G. Wozniak, T. Noll, H. Akinturk, J. Thul, and M. Muller Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease Ann NY Acad Sci 936 2001 617 620 (Pubitemid 32613946)
113. K.F. Standeven, A.M. Carter, and P.J. Grant Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness Blood 110 2007 902 907 (Pubitemid 47267427)
114. G.J. Spalding, M. Hartrumpf, and T. Sierig Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM) Eur J Cardiothorac Surg 31 2007 1052 1057 (Pubitemid 46719967)
115. J.H. Levy, R. Gill, and N.A. Nussmeier Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer A preliminary report Thromb Haemost 102 2009 765 771
116. I. MacGregor, J. Hope, and G. Barnard Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components Vox Sang 77 1999 88 96 (Pubitemid 29440780)
117. N. Blumberg, H. Zhao, and H. Wang The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients Transfusion 47 2007 573 581 (Pubitemid 46449617)
118. D. Fergusson, M.P. Khanna, A. Tinmouth, and P.C. Hebert Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials Can J Anaesth 51 2004 417 424
119. R.S. Friese, J.L. Sperry, H.A. Phelan, and L.M. Gentilello The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients Am J Surg 196 2008 56 61 (Pubitemid 351858572)
120. A.B. Nathens, T.A. Nester, G.D. Rubenfeld, R. Nirula, and T.B. Gernsheimer The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial Shock 26 2006 342 347 (Pubitemid 44402017)
121. J.P. Wallis, C.E. Chapman, K.E. Orr, S.C. Clark, and J.R. Forty Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery Transfusion 42 2002 1127 1134
122. Y.M. Bilgin, L.M. van de Watering, and L. Eijsman Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis Transfus Med 17 2007 304 311 (Pubitemid 47197755)
123. E.C. Vamvakas White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis Vox Sang 92 2007 224 232 (Pubitemid 46365029)
124. E.C. Vamvakas, and M.A. Blajchman Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention Blood 113 2009 3406 3417
125. L.M. Williamson, D. Stainsby, and H. Jones The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease Transfusion 47 2007 1455 1467 (Pubitemid 47101067)
126. K.E. King, R.S. Shirey, and S.K. Thoman Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs Transfusion 44 2004 25 29 (Pubitemid 38177132)
127. C.A. Llewelyn, R.S. Taylor, and A.A. Todd The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery Transfusion 44 2004 489 500 (Pubitemid 38437583)
128. H.A. Phelan, J.L. Sperry, and R.S. Friese Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients J Surg Res 138 2007 32 36 (Pubitemid 46227460)
129. T.R. Watkins, G.D. Rubenfeld, and T.R. Martin Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial Crit Care Med 36 2008 1493 1499 (Pubitemid 351620664)
130. M.K. Fung, K. Moore, M. Ridenour, W. Mook, and D.J. Triulzi Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery Transfusion 46 2006 386 391 (Pubitemid 43334091)
131. P.C. Hebert, D. Fergusson, and M.A. Blajchman Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions JAMA 289 2003 1941 1949 (Pubitemid 37430225)
132. D. Plurad, H. Belzberg, and I. Schulman Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury Am Surg 74 2008 117 123 (Pubitemid 351412519)
133. A.D. Sharma, T.F. Slaughter, and F.M. Clements Association of leukocyte-depleted blood transfusions with infectious complications after cardiac surgery Surg Infect (Larchmt) 3 2002 127 133
134. L.M. van de Watering, J. Hermans, and J.G. Houbiers Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial Circulation 97 1998 562 568 (Pubitemid 28090685)
135. L. Capraro, A. Kuitunen, and A.E. Vento Universal leukocyte reduction of transfused red cells does not provide benefit to patients undergoing cardiac surgery J Cardiothorac Vasc Anesth 21 2007 232 236 (Pubitemid 46528301)
136. I. Cleemput, M. Leys, D. Ramaekers, and L. Bonneux Balancing evidence and public opinion in health technology assessments: the case of leukoreduction Int J Technol Assess Health Care 22 2006 403 407 (Pubitemid 44622959)
137. M. van Hulst, Y.M. Bilgin, and L.M. van de Watering Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery Transfus Med 15 2005 209 217 (Pubitemid 40827474)
138. T. Frietsch, R. Karger, and M. Scholer Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay Transfusion 48 2008 2133 2142
139. O. Warren, S. Wallace, and R. Massey Does systemic leukocyte filtration affect perioperative hemorrhage in cardiac surgery? A systematic review and meta-analysis ASAIO J 53 2007 514 521 (Pubitemid 47220798)
140. O.J. Warren, E.M. Alcock, and A.M. Choong Recombinant activated factor VII: a solution to refractory haemorrhage in vascular surgery? Eur J Vasc Endovasc Surg 35 2008 145 152 (Pubitemid 351163079)
141. H.K. Lim, J. Anderson, and J.Y. Leong What is the role of leukocyte depletion in cardiac surgery? Heart Lung Circ 16 2007 243 253 (Pubitemid 47010463)
142. C. Bolcal, H.T. Akay, and H. Bingol Leukodepletion improves renal function in patients with renal dysfunction undergoing on-pump coronary bypass surgery: a prospective randomized study Thorac Cardiovasc Surg 55 2007 89 93 (Pubitemid 47234726)
143. S. Gunaydin, K. Ayrancioglu, and E. Dikmen Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts Perfusion 22 2007 279 288 (Pubitemid 350200815)
144. F. Bakhtiary, A. Moritz, and P. Kleine Leukocyte depletion during cardiac surgery with extracorporeal circulation in high-risk patients Inflamm Res 57 2008 577 585
145. J. Boldt, B. Zickmann, and M. Ballesteros Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery J Cardiothorac Vasc Anesth 7 1993 4 9 (Pubitemid 23065628)
146. F. Al-Rashidi, M. Bhat, L. Pierre, and B. Koul Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation Interact Cardiovasc Thorac Surg 6 2007 618 622 (Pubitemid 47598513)
147. C.C. Trowbridge, A.H. Stammers, and E. Woods Use of platelet gel and its
148. K. Karkouti, W.S. Beattie, and D.N. Wijeysundera Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery J Thorac Cardiovasc Surg 129 2005 391 400 (Pubitemid 40169564)
149. A.S. Tomar, D.K. Tempe, and A. Banerjee Preoperative autologous plateletpheresis in patients undergoing open heart surgery Ann Card Anaesth 6 2003 136 142
150. S.M. Ford, M.J. Unsworth-White, and T. Aziz Platelet pheresis is not a useful adjunct to blood-sparing strategies in cardiac surgery J Cardiothorac Vasc Anesth 16 2002 321 329 (Pubitemid 34701184)
151. P. Wajon, J. Gibson, R. Calcroft, C. Hughes, and B. Thrift Intraoperative plateletpheresis and autologous platelet gel do not reduce chest tube drainage or allogeneic blood transfusion after reoperative coronary artery bypass graft Anesth Analges 93 2001 536 542 (Pubitemid 32785288)
152. M. Yokomuro, K. Ebine, and K. Shiroma Safety and efficacy of autologous platelet transfusion in cardiac surgery: comparison of cryopreservation, blood collection on the day before surgery, and blood collection during surgery Cryobiology 38 1999 236 242 (Pubitemid 29399451)
153. T. Menges, I. Welters, and R.M. Wagner The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery Eur J Cardiothorac Surg 11 1997 557 563 (Pubitemid 27147923)
154. J.T. Christenson, J. Reuse, P. Badel, F. Simonet, and M. Schmuziger Plateletpheresis before redo CABG diminishes excessive blood transfusion Ann Thorac Surg 62 1996 1373 1379
155. J.T. Christenson, J. Reuse, and P. Badel Autologous platelet sequestration in patients undergoing coronary artery bypass grafting Eur J Cardiothorac Surg 10 1996 1083 1089 (Pubitemid 126690854)
156. L. Shore-Lesserson, D.L. Reich, M. DePerio, and G. Silvay Autologous platelet-rich plasmapheresis: risk versus benefit in repeat cardiac operations Anesth Analges 81 1995 229 235
157. C.A. Wong, M.L. Franklin, and L.D. Wade Coagulation tests, blood loss, and transfusion requirements in platelet-rich plasmapheresed versus nonpheresed cardiac surgery patients Anesth Analges 78 1994 29 36 (Pubitemid 24012598)
158. E.P. Stover, and L.C. Siegel Platelet-rich plasmapheresis in cardiac surgery: efficacy may yet be demonstrated J Thorac Cardiovasc Surg 108 1994 1148 1149 (Pubitemid 24379871)
159. A.H. Stammers, J. Kratz, T. Johnson, J. Crumbley, and J. Merrill Hematological assessment of patients undergoing plasmapheresis during cardiac surgery J Extracorpor Technol 25 1993 6 14 (Pubitemid 23135959)
160. M.H. Ereth, W.C. Oliver, and F.M. Beynen Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery Anesthesiology 79 1993 540 547 discussion 527A
161. S.K. Boey, B.C. Ong, and S.S. Dhara Preoperative plateletpheresis does not reduce blood loss during cardiac surgery Can J Anaesth 40 1993 844 850 (Pubitemid 23325792)
162. G.G. Davies, D.G. Wells, and R. Sadler Plateletpheresis and transfusion practice in heart operations Ann Thorac Surg 54 1992 1020
163. J.W. Jones, T.A. McCoy, R.E. Rawitscher, and D.A. Lindsley Effects of intraoperative plasmapheresis on blood loss in cardiac surgery Ann Thorac Surg 49 1990 585 590 (Pubitemid 20149259)
164. J. Boldt, B. von Bormann, and D. Kling Preoperative plasmapheresis in patients undergoing cardiac surgery procedures Anesthesiology 72 1990 282 288 (Pubitemid 20057995)
165. S. Li, H. Ji, and J. Lin Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery J Extracorpor Technol 37 2005 9 14 (Pubitemid 40316263)
166. H. Harke, D. Tanger, S. Furst-Denzer, C. Paoachrysanthou, and A. Bernhard [Effect of a preoperative separation of platelets on the postoperative blood loss subsequent to extracorporeal circulation in open heart surgery (author's translation)] Anaesthesist 26 1977 64 71 (Pubitemid 8034455)
167. T.L. Simon, B.F. Akl, and W. Murphy Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery Ann Thorac Surg 37 1984 359 364 (Pubitemid 14138283)
168. S.A. Harding, M.A. Shakoor, and A.J. Grindon Platelet support for cardiopulmonary bypass surgery J Thorac Cardiovasc Surg 70 1975 350 353
169. J. Lavee, U. Martinowitz, and R. Mohr The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations A scanning electron microscope study of platelet aggregation on extracellular matrix J Thorac Cardiovasc Surg 97 1989 204 212 (Pubitemid 19061422)
170. R. Mohr, U. Martinowitz, and J. Lavee The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations J Thorac Cardiovasc Surg 96 1988 530 534
171. V.A. Ferraris, W.R. Berry, and R.R. Klingman Comparison of blood reinfusion techniques used during coronary artery bypass grafting Ann Thorac Surg 56 1993 433 440 (Pubitemid 23294399)
172. R. Gill, M. Herbertson, and A. Vuylsteke Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery Circulation 120 2009 21 27
173. M. Ranucci, G. Isgro, G. Soro, D. Conti, and B. De Toffol Efficacy and safety of recombinant activated factor vii in major surgical procedures: systematic review and meta-analysis of randomized clinical trials Arch Surg 143 2008 296 304 (Pubitemid 351439290)
174. C. von Heymann, S. Jonas, and C. Spies Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data Crit Care 12 2008 R14
175. M. Levi, M. Peters, and H.R. Buller Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review Crit Care Med 33 2005 883 890
176. J.F. Hardy, S. Belisle, and P. Van der Linden Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials Ann Thorac Surg 86 2008 1038 1048
177. K. Karkouti, W.S. Beattie, and R. Arellano Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery Circulation 118 2008 331 338
178. S. Dunkley, L. Phillips, and P. McCall Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry Ann Thorac Surg 85 2008 836 844 (Pubitemid 351255532)
179. G.J. Despotis, V. Levine, J.H. Joist, D. Joiner-Maier, and E. Spitznagel Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation Anesth Analges 85 1997 498 506 (Pubitemid 27381298)
180. R.S. Schwartz, K.A. Bauer, and R.D. Rosenberg Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin The Antithrombin III Study Group Am J Med 87 Suppl 1989 53 60
181. K. Hashimoto, M. Yamagishi, T. Sasaki, M. Nakano, and H. Kurosawa Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation Ann Thorac Surg 58 1994 799 804 (Pubitemid 24319632)
182. L.A. Wolk, R.F. Wilson, and M. Burdick Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass Am Surg 51 1985 309 313 (Pubitemid 15049550)
183. W.H. Matthai, P.B. Kurnik, W.C. Groh, W.J. Untereker, and J.E. Siegel Antithrombin activity during the period of percutaneous coronary revascularization: relation to heparin use, thrombotic complications and restenosis J Am Coll Cardiol 33 1999 1248 1256
184. G.J. Despotis, J.H. Joist, and C.W. Hogue More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT Thromb Haemost 76 1996 902 908 (Pubitemid 27013627)
185. J.G. Ray, S. Deniz, and A. Olivieri Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel BMC Cardiovasc Disord 3 2003 3
186. J. Hirsh Heparin N Engl J Med 324 1991 1565 1574
187. M. Ranucci, G. Isgro, and A. Cazzaniga Different patterns of heparin resistance: therapeutic implications Perfusion 17 2002 199 204 (Pubitemid 34467126)
188. E. Young, M. Prins, M.N. Levine, and J. Hirsh Heparin binding to plasma proteins, an important mechanism for heparin resistance Thromb Haemost 67 1992 639 643
189. K.T. Preissner, and G. Muller-Berghaus Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III Involvement of an inducible heparin-binding domain of S protein/vitronectin J Biol Chem 262 1987 12247 12253 (Pubitemid 17131665)
190. K.H. Teoh, E. Young, C.A. Bradley, and J. Hirsh Heparin binding proteins Contribution to heparin rebound after cardiopulmonary bypass Circulation 88 1993 II420 II425
191. D.A. Lane, G. Pejler, A.M. Flynn, E.A. Thompson, and U. Lindahl Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4 J Biol Chem 261 1986 3980 3986 (Pubitemid 17198823)
192. H.F. Wu, R.L. Lundblad, and F.C. Church Neutralization of heparin activity by neutrophil lactoferrin Blood 85 1995 421 428
193. J.R. Zaidan, S. Johnson, R. Brynes, S. Monroe, and A.V. Guffin Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery Anesth Analges 65 1986 377 380 (Pubitemid 16162566)
194. W. Dietrich, M. Spannagl, and W. Schramm The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass J Thorac Cardiovasc Surg 102 1991 505 514
195. R.A. Esposito, A.T. Culliford, and S.B. Colvin Heparin resistance during cardiopulmonary bypass The role of heparin pretreatment J Thorac Cardiovasc Surg 85 1983 346 353 (Pubitemid 13093724)
196. A.H. Sabbagh, G.K. Chung, P. Shuttleworth, B.J. Applegate, and W. Gabrhel Fresh frozen plasma: a solution to heparin resistance during cardiopulmonary bypass Ann Thorac Surg 37 1984 466 468 (Pubitemid 14077464)
197. E.L. Heller, and L. Paul Anticoagulation management in a patient with an acquired antithrombin III deficiency J Extracorpor Technol 33 2001 245 248 (Pubitemid 34142995)
198. J.H. Levy, G.J. Despotis, and F. Szlam Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study Anesthesiology 96 2002 1095 1102 (Pubitemid 34462569)
199. K. Karkouti, D.N. Wijeysundera, and T.M. Yau Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery Can J Anaesth 53 2006 279 287
200. G.A. Van Norman, T. Gernsheimer, W.L. Chandler, R.P. Cochran, and B.D. Spiess Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency J Cardiothorac Vasc Anesth 11 1997 760 763 (Pubitemid 27408675)
201. J.C. Conley, and P.F. Plunkett Antithrombin III in cardiac surgery: an outcome study J Extracorpor Technol 30 1998 178 183 (Pubitemid 29152673)
202. M. Kanbak The treatment of heparin resistance with antithrombin III in cardiac surgery Can J Anaesth 46 1999 581 585 (Pubitemid 29327686)
203. M.R. Williams, A.B. D'Ambra, and J.R. Beck A randomized trial of antithrombin concentrate for treatment of heparin resistance Ann Thorac Surg 70 2000 873 877
204. J.H. Lemmer, and G.J. Despotis Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery J Thorac Cardiovasc Surg 123 2002 213 217 (Pubitemid 34127106)
205. A.F. Eder, J.M. Kennedy, and B.A. Dy Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (20042006) Transfusion 47 2007 1134 1142 (Pubitemid 46934307)
206. K. Hashimoto, H. Kurosawa, and K. Tanaka Total cavopulmonary connection without the use of prosthetic material: technical considerations and hemodynamic consequences J Thorac Cardiovasc Surg 110 1995 625 632
207. Y. Okita, S. Takamoto, and M. Ando Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization Circulation 96 1997 II-376 II-381
208. G.J. Despotis, J.H. Joist, and C.W. Hogue The impact of heparin concentration and activated clotting time monitoring on blood conservation A prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 110 1995 46 54
209. W. Dietrich, G. Dilthey, M. Spannagl, and J.A. Richter Warfarin pretreatment does not lead to increased bleeding tendency during cardiac surgery J Cardiothorac Vasc Anesth 9 1995 250 254
210. A. Tinmouth, and I. Chin-Yee The clinical consequences of the red cell storage lesion Transfus Med Rev 15 2001 91 107 (Pubitemid 32303574)
211. V.A. Ferraris, S.P. Ferraris, and A. Singh The platelet thrombin receptor and postoperative bleeding Ann Thorac Surg 65 1998 352 358 (Pubitemid 28083327)
212. L.E. Nielsen, W.R. Bell, A.M. Borkon, and C.A. Neill Extensive thrombus formation with heparin resistance during extracorporeal circulation A new presentation of familial antithrombin III deficiency Arch Intern Med 147 1987 149 152 (Pubitemid 17010775)
213. S.W. Heindel, M.R. Mill, and E.B. Freid Fatal thrombosis associated with a hemi-Fontan procedure, heparin-protamine reversal, and aprotinin Anesthesiology 94 2001 369 371 (Pubitemid 32125935)
214. J.B. Holcomb, D. Jenkins, and P. Rhee Damage control resuscitation: directly addressing the early coagulopathy of trauma J Trauma 62 2007 307 310
215. D. Stainsby, H. Jones, and D. Asher Serious hazards of transfusion: a decade of hemovigilance in the UK Transfus Med Rev 20 2006 273 282 (Pubitemid 44428107)
216. M. Ranucci, A. Frigiola, and L. Menicanti Postoperative antithrombin levels and outcome in cardiac operations Crit Care Med 33 2005 355 360 (Pubitemid 40216549)
217. C.V. Bishop, W.E. Renwick, and C. Hogan Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery Ann Thorac Surg 81 2006 875 879 (Pubitemid 43247653)
218. A. Breitenstein, G.G. Camici, and F.C. Tanner Tissue factor: beyond coagulation in the cardiovascular system Clin Sci (Lond) 118 2010 159 172
219. E.F. Krakow, I. Walker, A. Lamy, and J.A. Anderson Cardiac surgery in patients with haemophilia B: a case report and review of the literature Haemophilia 15 2009 108 113
220. D. Grandmougin, M.C. Delolme, J. Reynaud, and X. Barral Off-pump myocardial revascularization in a diabetic patient with severe hemophilia B and impaired left ventricular function: hematological and operative strategies J Card Surg 20 2005 366 369 (Pubitemid 40992560)
221. A. Mazzucco, G. Stellin, and P. Cantele Repair of ventricular septal defect and aortic regurgitation associated with severe hemophilia B Ann Thorac Surg 42 1986 97 99 (Pubitemid 16088472)
222. D. Bolliger, G. Sreeram, and A. Duncan Prophylactic use of factor IX concentrate in a Jehovah's Witness patient Ann Thorac Surg 88 2009 1666 1668
223. F.E. Preston, S.T. Laidlaw, B. Sampson, and S. Kitchen Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients Br J Haematol 116 2002 619 624 (Pubitemid 34178663)
224. H. Luu, and B. Ewenstein FEIBA safety profile in multiple modes of clinical and home-therapy application Haemophilia 10 Suppl 2 2004 10 16 (Pubitemid 40045405)
225. R. Sniecinski, and J.H. Levy What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery Anesth Analges 104 2007 753 754 (Pubitemid 46548289)
226. O. Muramoto Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses BMJ 322 2001 37 39 (Pubitemid 32066261)
227. D.M. Moskowitz, S.I. Perelman, and K.M. Cousineau Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium Can J Anaesth 49 2002 402 408 (Pubitemid 34546173)
228. Council on Scientific Affairs Autologous blood transfusions JAMA 256 1986 2378 2380
229. T. Hirano, J. Yamanaka, Y. Iimuro, and J. Fujimoto Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma Surg Today 35 2005 1042 1046 (Pubitemid 41772300)
230. F. Muscari, B. Suc, and D. Vigouroux Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int 18 2005 1236 1239 (Pubitemid 41726743)
231. R.A. Zulim, M. Rocco, and J.E. Goodnight Intraoperative autotransfusion in hepatic resection for malignancy Is it safe? Arch Surg 128 1993 206 211 (Pubitemid 23057646)
232. M. Davis, M. Sofer, O. Gomez-Marin, D. Bruck, and M.S. Soloway The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? Br J Urol Int 91 2003 474 476 (Pubitemid 36570563)
233. C.L. Gray, C.L. Amling, G.R. Polston, C.R. Powell, and C.J. Kane Intraoperative cell salvage in radical retropubic prostatectomy Urology 58 2001 740 745
234. J.T. Stoffel, L. Topjian, and J.A. Libertino Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy Br J Urol Int 96 2005 313 315 (Pubitemid 41097672)
235. R. Mirhashemi, H.E. Averette, and K. Deepika The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer Am J Obstet Gynecol 181 1999 1310 1316 (Pubitemid 30021869)
236. J.P. Connor, P.C. Morris, and T. Alagoz Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix Obstet Gynecol 86 1995 373 378
237. I. Klimberg, R. Sirois, Z. Wajsman, and J. Baker Intraoperative autotransfusion in urologic oncology Arch Surg 121 1986 1326 1329 (Pubitemid 17180522)
238. O.J. Hart, I.W. Klimberg, Z. Wajsman, and J. Baker Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder Surg Gynecol Obstet 168 1989 302 306 (Pubitemid 19120566)
239. A.J. Salsbury The significance of the circulating cancer cell Cancer Treat Rev 2 1975 55 72
240. W.H. Cole The mechanisms of spread of cancer Surg Gynecol Obstet 137 1973 853 871
241. E.C. Vamvakas Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation Transfusion 35 1995 760 768
242. A.C. Amato, and M. Pescatori Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors Dis Colon Rectum 41 1998 570 585 (Pubitemid 28224088)
243. M.J. Edelman, P. Potter, K.G. Mahaffey, R. Frink, and R.B. Leidich The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter Urology 47 1996 179 181 (Pubitemid 26075270)
244. P. Perseghin, M. Vigano, and G. Rocco Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients Vox Sang 72 1997 221 224 (Pubitemid 27277714)
245. G.V. Miller, C.W. Ramsden, and J.N. Primrose Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer Br J Surg 78 1991 713 715
246. E. Hansen, R. Knuechel, J. Altmeppen, and K. Taeger Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells Transfusion 39 1999 608 615 (Pubitemid 29275331)
247. J. Boldt, D. Kling, and B. von Bormann Blood conservation in cardiac operations Cell separation versus hemofiltration J Thorac Cardiovasc Surg 97 1989 832 840 (Pubitemid 19154426)
248. R.G. Sutton, J.M. Kratz, F.G. Spinale, and F.A. Crawford Jr Comparison of three blood-processing techniques during and after cardiopulmonary bypass Ann Thorac Surg 56 1993 938 943 (Pubitemid 23316077)
249. I. Eichert, F. Isgro, A.H. Kiessling, and W. Saggau Cell saver, ultrafiltration and direct transfusion: comparative study of three blood processing techniques Thorac Cardiovasc Surg 49 2001 149 152 (Pubitemid 32923824)
250. K.A. Samolyk, S.R. Beckmann, and R.C. Bissinger A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag Perfusion 20 2005 343 349 (Pubitemid 41824364)
251. C.R. Daane, H.D. Golab, J.H. Meeder, M.J. Wijers, and A.J. Bogers Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume Perfusion 18 2003 115 121 (Pubitemid 36850195)
252. B.H. Walpoth, N. Eggensperger, and S.P. Hauser Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery Int J Artif Organs 22 1999 210 216 (Pubitemid 29290735)
253. A. Wiefferink, P.W. Weerwind, and W. van Heerde Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements J Extracorpor Technol 39 2007 66 70 (Pubitemid 351506718)
254. J.M. Moran, R. Babka, and S. Silberman Immediate centrifugation of oxygenator contents after cardiopulmonary bypass Role in maximum blood conservation J Thorac Cardiovasc Surg 76 1978 510 517 (Pubitemid 9054058)
255. M.D. Dake, D.C. Miller, and C.P. Semba Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms N Engl J Med 331 1994 1729 1734
256. D. Cheng, J. Martin, and H. Shennib Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease: a systematic review and meta-analysis of comparative studies J Am Coll Cardiol 55 2010 986 1001
257. S.R. Walsh, T.Y. Tang, and U. Sadat Endovascular stenting versus open surgery for thoracic aortic disease: systematic review and meta-analysis of perioperative results J Vasc Surg 47 2008 1094 1098
258. I.A. Rahman, T. Hoth, H. Doughty, and R.S. Bonser Thoraco-abdominal aneurysm repair in a Jehovah's Witness: maximising blood conservation Perfusion 22 2007 363 364 (Pubitemid 351516049)
259. T. Kadohama, N. Akasaka, and T. Sasajima Staged repair for a chronic dissecting thoracic aortic aneurysm with no transfusion in a Jehovah's Witness patient Gen Thorac Cardiovasc Surg 55 2007 262 265 (Pubitemid 46985994)
260. J.L. Barnum, and J.J. Sistino Renal dysfunction in cardiac surgery: identifying potential risk factors Perfusion 24 2009 139 142
261. D. Bainbridge, J. Martin, and D. Cheng Off pump coronary artery bypass graft surgery versus conventional coronary artery bypass graft surgery: a systematic review of the literature Semin Cardiothorac Vasc Anesth 9 2005 105 111 (Pubitemid 40328240)
262. R. Pandey, A.D. Grayson, D.M. Pullan, B.M. Fabri, and W.C. Dihmis Total arterial revascularisation: effect of avoiding cardiopulmonary bypass on in-hospital mortality and morbidity in a propensity-matched cohort Eur J Cardiothorac Surg 27 2005 94 98 (Pubitemid 40038535)
263. R.H. Jones Intraoperative crossover: the well-kept surgical secret to apparent surgical success J Am Coll Cardiol 45 2005 1529 1531 (Pubitemid 40615629)
264. A. Parolari, F. Alamanni, and G. Polvani Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency Ann Thorac Surg 80 2005 2121 2125 (Pubitemid 41718039)
265. S.C. Provenzano, R. Stacey, and D.C. Newman A simple system to deliver blood cardioplegia Ann Thorac Surg 80 2005 1946 1947 (Pubitemid 41464348)
266. M.S. Slater, C.B. Komanapalli, and H.K. Song Myocardial protection G.P. Gravlee, Cardiopulmonary bypass: principles and practice 3rd ed. 2008 Wolters Kluwer/Lippincott Williams & Wilkins Philadelphia 177
267. I. el-Hamamsy, L.M. Stevens, and M. Pellerin A prospective randomized study of diluted versus non-diluted cardioplegia (minicardioplegia) in primary coronary artery bypass surgery J Cardiovasc Surg 45 2004 101 106 (Pubitemid 39023207)
268. N. Hayashida, T. Isomura, and T. Sato Minimally diluted tepid blood cardioplegia Ann Thorac Surg 65 1998 615 621 (Pubitemid 28162450)
269. P. Menasche, J.P. Fleury, and L. Veyssie Limitation of vasodilation associated with warm heart operation by a "mini-cardioplegia" delivery technique Ann Thorac Surg 56 1993 1148 1153 (Pubitemid 23337607)
270. T.B. Albacker, R. Chaturvedi, and A.H. Al Kindi The effect of using microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery Interact Cardiovasc Thorac Surg 9 2009 56 60
271. L. Vercaemst Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm J Extracorpor Technol 40 2008 257 267
272. P.S. Hsu, J.L. Chen, and G.J. Hong Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients Eur J Cardiothorac Surg 37 2009 328 333
273. K.G. Shann, C.R. Giacomuzzi, and L. Harness Complications relating to perfusion and extracorporeal circulation associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease Cardiol Young 18 Suppl 2 2008 206 214
274. Extracorporeal Life Support Organization (ELSO) General Guidelines for all ECLS Cases http://www.elso.med.umich.edu/WordForms/ ELSO%20Guidelines%20General%20All%20ECLS%20Version1.1.pdf 2009
275. R.R. Thiagarajan, T.V. Brogan, and M.A. Scheurer Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults Ann Thorac Surg 87 2009 778 785
276. V. Kasirajan, N.G. Smedira, and J.F. McCarthy Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation Eur J Cardiothorac Surg 15 1999 508 514 (Pubitemid 29210357)
277. T.M. Robinson, T.S. Kickler, L.K. Walker, P. Ness, and W. Bell Effect of extracorporeal membrane oxygenation on platelets in newborns Crit Care Med 21 1993 1029 1034 (Pubitemid 23206195)
278. F.B. Plotz, W. van Oeveren, R.H. Bartlett, and C.R. Wildevuur Blood activation during neonatal extracorporeal life support J Thorac Cardiovasc Surg 105 1993 823 832 (Pubitemid 23151813)
279. L. Lequier Extracorporeal life support in pediatric and neonatal critical care: a review J Intens Care Med 19 2004 243 258
280. S.F. Marasco, G. Lukas, M. McDonald, J. McMillan, and B. Ihle Review of ECMO (extracorporeal membrane oxygenation) support in critically ill adult patients Heart Lung Circ 17 Suppl 4 2008 41 47
281. C.A. Nankervis, T.J. Preston, and K.C. Dysart Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation ASAIO J 53 2007 111 114 (Pubitemid 46145500)
282. C.W. Baird, D. Zurakowski, and B. Robinson Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival Ann Thorac Surg 83 2007 912 920 (Pubitemid 46328806)
283. M. Glauber, J. Szefner, and M. Senni Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol Int J Artif Organs 18 1995 649 655
284. S. Agati, G. Ciccarello, and D. Salvo Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience ASAIO J 52 2006 513 516 (Pubitemid 44394258)
285. K. Sung, Y.T. Lee, and P.W. Park Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support Ann Thorac Surg 82 2006 651 656 (Pubitemid 44080028)
286. D.D. Muehrcke, P.M. McCarthy, and R.W. Stewart Complications of extracorporeal life support systems using heparin-bound surfaces The risk of intracardiac clot formation J Thorac Cardiovasc Surg 110 1995 843 851
287. J. Borowiec, S. Thelin, L. Bagge, J. Hultman, and H.E. Hansson Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose Scand J Thorac Cardiovasc Surg 26 1992 177 185 (Pubitemid 23060464)
288. C. Bauer, Z. Vichova, and P. Ffrench Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism Anesth Analges 106 2008 1101 1103 table of contents (Pubitemid 351450531)
289. S.K. Balasubramanian, R. Tiruvoipati, S. Chatterjee, A. Sosnowski, and R.K. Firmin Extracorporeal membrane oxygenation with lepirudin anticoagulation for Wegener's granulomatosis with heparin-induced thrombocytopenia ASAIO J 51 2005 477 479 (Pubitemid 41076787)
290. A. Koster, Y. Weng, and W. Bottcher Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT Ann Thorac Surg 83 2007 1865 1867 (Pubitemid 46616760)
291. B. Mejak, C. Giacomuzzi, and E. Heller Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia J Extracorpor Technol 36 2004 178 181 (Pubitemid 38924747)
292. F. Brunet, J.P. Mira, and M. Belghith Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal Intens Care Med 18 1992 364 367
293. C.D. Downard, P. Betit, and R.W. Chang Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review J Pediatr Surg 38 2003 1212 1216 (Pubitemid 37048044)
294. F.H. van der Staak, A.F. de Haan, W.B. Geven, and C. Festen Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid J Pediatr Surg 32 1997 594 599 (Pubitemid 27175771)
295. J.M. Wilson, L.K. Bower, and J.C. Fackler Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO J Pediatr Surg 28 1993 536 541 (Pubitemid 23127619)
296. J.R. Horwitz, B.R. Cofer, B.W. Warner, H.W. Cheu, and K.P. Lally A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO J Pediatr Surg 33 1998 1610 1613 (Pubitemid 28530409)
297. A. Sahlman, J. Ahonen, J.A. Salo, and O.J. Ramo No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass Acta Anaesthesiol Scand 45 2001 558 563 (Pubitemid 32417464)
298. S.C. Chevuru, M.C. Sola, and D.W. Theriaque Multicenter analysis of platelet transfusion usage among neonates on extracorporeal membrane oxygenation Pediatrics 109 2002 e89
299. A. Stallion, B.R. Cofer, J.A. Rafferty, M.M. Ziegler, and F.C. Ryckman The significant relationship between platelet count and haemorrhagic complications on ECMO Perfusion 9 1994 265 269 (Pubitemid 24255379)
300. M.L. Dohner, S.E. Wiedmeier, and R.A. Stoddard Very high users of platelet transfusions in the neonatal intensive care unit Transfusion 49 2009 869 872
301. S.F. Marasco, A. Preovolos, K. Lim, and R.F. Salamonsen Thoracotomy in adults while on ECMO is associated with uncontrollable bleeding Perfusion 22 2007 23 26 (Pubitemid 47018358)
302. T.J. Preston, V.F. Olshove, O. Ayad, K.K. Nicol, and J.B. Riley Novoseven use in a non-cardiac pediatric ECMO patient with uncontrolled bleeding J Extracorpor Technol 40 2008 123 126
303. A. Verrijckt, F. Proulx, S. Morneau, and S. Vobecky Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation J Thorac Cardiovasc Surg 127 2004 1812 1813 (Pubitemid 38725466)
304. R.A. Niebler, R.C. Punzalan, M. Marchan, and M.W. Lankiewicz Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation Pediatr Crit Care Med 11 2010 98 102
305. M. Swaminathan, A.D. Shaw, R.A. Greenfield, and K.P. Grichnik Fatal thrombosis after factor VII administration during extracorporeal membrane oxygenation J Cardiothorac Vasc Anesth 22 2008 259 260 (Pubitemid 351423683)
306. C. von Heymann, S. Ziemer, W.J. Kox, and C. Spies Caveat against the use of feiba in combination with recombinant factor viia J Thorac Cardiovasc Surg 126 2003 1667 1668 (Pubitemid 37449216)
307. M. Ranucci, D. Conti, and S. Castelvecchio Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients Ann Thorac Surg 89 2010 11 17
308. G. Nollert, I. Schwabenland, and D. Maktav Miniaturized cardiopulmonary bypass in coronary artery bypass surgery: marginal impact on inflammation and coagulation but loss of safety margins Ann Thorac Surg 80 2005 2326 2332 (Pubitemid 41718082)
309. T.A. Folliguet, E. Villa, F. Vandeneyden, and F. Laborde Coronary artery bypass graft with minimal extracorporeal circulation Heart Surg Forum 6 2003 297 301 (Pubitemid 37304571)
310. S. Beholz, L. Zheng, M. Kessler, M. Rusche, and W. Konertz A new PRECiSe (priming reduced extracorporeal circulation setup) minimizes the need for blood transfusions: first clinical results in coronary artery bypass grafting Heart Surg Forum 8 2005 E132 E135
311. H.A. Vohra, R. Whistance, A. Modi, and S.K. Ohri The inflammatory response to miniaturised extracorporeal circulation: a review of the literature Mediators Inflamm 2009 2009 707042
312. V. Svitek, V. Lonsky, and J. Mandak No clear clinical benefit of using mini-invasive extracorporeal circulation in coronary artery bypass grafting in low-risk patients Perfusion 24 2009 389 395
313. F.F. Immer, A. Ackermann, and E. Gygax Minimal extracorporeal circulation is a promising technique for coronary artery bypass grafting Ann Thorac Surg 84 2007 1515 1521 (Pubitemid 47588122)
314. A. Castiglioni, A. Verzini, and F. Pappalardo Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement Ann Thorac Surg 83 2007 586 591 (Pubitemid 46135455)
315. S.S. Just, T. Muller, and J.M. Albes Minimized closed circuit/centrifugal pump extracorporeal circulation: an effective aid in coronary bypass operations in Jehovah's Witnesses Interact Cardiovasc Thorac Surg 6 2007 124 125
316. A.B. Brest van Kempen, J.M. Gasiorek, K. Bloemendaal, R.P. Storm van Leeuwen, and E.R. Bulder Low-prime perfusion circuit and autologous priming in CABG surgery on a Jehovah's Witness: a case report Perfusion 17 2002 69 72 (Pubitemid 34071711)
317. W.J. van Boven, W.B. Gerritsen, F.G. Waanders, F.J. Haas, and L.P. Aarts Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function Perfusion 19 2004 239 246 (Pubitemid 39173455)
318. U. Abdel-Rahman, F. Ozaslan, and P.S. Risteski Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit? Ann Thorac Surg 80 2005 238 243 (Pubitemid 40840215)
319. C. Beghi, F. Nicolini, and A. Agostinelli Mini-cardiopulmonary bypass system: results of a prospective randomized study Ann Thorac Surg 81 2006 1396 1400
320. R.A. Huybregts, A.M. Morariu, and G. Rakhorst Attenuated renal and intestinal injury after use of a mini-cardiopulmonary bypass system Ann Thorac Surg 83 2007 1760 1766 (Pubitemid 46616809)
321. H. Kamiya, T. Kofidis, A. Haverich, and U. Klima Preliminary experience with the mini-extracorporeal circulation system (Medtronic resting heart system) Interact Cardiovasc Thorac Surg 5 2006 680 682 (Pubitemid 44901220)
322. A. Liebold, A. Khosravi, and B. Westphal Effect of closed minimized cardiopulmonary bypass on cerebral tissue oxygenation and microembolization J Thorac Cardiovasc Surg 131 2006 268 276 (Pubitemid 43121546)
323. T. Ohata, M. Mitsuno, and M. Yamamura Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution ASAIO J 54 2008 207 209 (Pubitemid 351450768)
324. M. Perthel, L. El-Ayoubi, A. Bendisch, J. Laas, and M. Gerigk Clinical advantages of using mini-bypass systems in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective Eur J Cardiothorac Surg 31 2007 1070 1075 (Pubitemid 46719957)
325. J.P. Remadi, Z. Rakotoarivelo, P. Marticho, and A. Benamar Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra system or with a standard cardiopulmonary bypass Am Heart J 151 2006 198
326. T. Kofidis, H. Baraki, and H. Singh The minimized extracorporeal circulation system causes less inflammation and organ damage Perfusion 23 2008 147 151
327. J. Wippermann, J.M. Albes, and M. Hartrumpf Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system Eur J Cardiothorac Surg 28 2005 127 132 (Pubitemid 40883946)
328. U. Benedetto, R. Luciani, and M. Goracci Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery Ann Thorac Surg 88 2009 529 535
329. Y. Fromes, D. Gaillard, and O. Ponzio Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation Eur J Cardiothorac Surg 22 2002 527 533 (Pubitemid 35286933)
330. F. Pappalardo, C. Corno, and A. Franco Reduction of hemodilution in small adults undergoing open heart surgery: a prospective, randomized trial Perfusion 22 2007 317 322 (Pubitemid 351516042)
331. U. Borrelli, N. Al-Attar, and M. Detroux Compact extracorporeal circulation: reducing the surface of cardiopulmonary bypass to improve outcomes Surg Technol Int 16 2007 159 166
332. C.L. Lau, K.E. Posther, and G.R. Stephenson Mini-circuit cardiopulmonary bypass with vacuum assisted venous drainage: feasibility of an asanguineous prime in the neonate Perfusion 14 1999 389 396 (Pubitemid 29423929)
333. S. Bevilacqua, S. Matteucci, and M. Ferrarini Biochemical evaluation of vacuum-assisted venous drainage: a randomized, prospective study Perfusion 17 2002 57 61 (Pubitemid 34071709)
334. S. Wang, K. Woitas, J.B. Clark, J.L. Myers, and A. Undar Clinical real-time monitoring of gaseous microemboli in pediatric cardiopulmonary bypass Artif Organs 33 2009 1026 1030
335. K.N. Win, S. Wang, and A. Undar Microemboli generation, detection and characterization during CPB procedures in neonates, infants, and small children ASAIO J 54 2008 486 490
336. T.J. Jones, D.D. Deal, J.C. Vernon, N. Blackburn, and D.A. Stump Does vacuum-assisted venous drainage increase gaseous microemboli during cardiopulmonary bypass? Ann Thorac Surg 74 2002 2132 2137 (Pubitemid 35440892)
337. M.J. Norman, J.J. Sistino, and J.R. Acsell The effectiveness of low-prime cardiopulmonary bypass circuits at removing gaseous emboli J Extracorpor Technol 36 2004 336 342 (Pubitemid 40082882)
338. M. Carrier, A. Cyr, and P. Voisine Vacuum-assisted venous drainage does not increase the neurological risk Heart Surg Forum 5 2002 285 288 (Pubitemid 35189524)
339. T.W. Willcox Vacuum-assisted venous drainage: to air or not to air, that is the question Has the bubble burst? J Extracorpor Technol 34 2002 24 28 (Pubitemid 34211778)
340. X.M. Mueller, H.T. Tevaearai, and J. Horisberger Vacuum assisted venous drainage does not increase trauma to blood cells ASAIO J 47 2001 651 654 (Pubitemid 33064159)
341. T.W. Willcox, S.J. Mitchell, and D.F. Gorman Venous air in the bypass circuit: a source of arterial line emboli exacerbated by vacuum-assisted drainage Ann Thorac Surg 68 1999 1285 1289
342. N. Colangelo, L. Torracca, and E. Lapenna Vacuum-assisted venous drainage in extrathoracic cardiopulmonary bypass management during minimally invasive cardiac surgery Perfusion 21 2006 361 365 (Pubitemid 46218364)
343. S. Cirri, L. Negri, and M. Babbini Haemolysis due to active venous drainage during cardiopulmonary bypass: comparison of two different techniques Perfusion 16 2001 313 318 (Pubitemid 32640541)
344. R.K. Mathews, and J.J. Sistino In-vitro evaluation of the hemolytic effects of augmented venous drainage J Extracorpor Technol 33 2001 15 18 (Pubitemid 32215955)
345. K. Ahlberg, J.J. Sistino, and S. Nemoto Hematological effects of a low-prime neonatal cardiopulmonary bypass circuit utilizing vacuum-assisted venous return in the porcine model J Extracorpor Technol 31 1999 195 201 (Pubitemid 30176835)
346. M. Ranucci, A. Balduini, A. Ditta, A. Boncilli, and S. Brozzi A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome Ann Thorac Surg 87 2009 1311 1319
347. M. Boodhwani, K. Williams, and A. Babaev Ultrafiltration reduces blood transfusions following cardiac surgery: A meta-analysis Eur J Cardiothorac Surg 30 2006 892 897 (Pubitemid 44738612)
348. B.H. Walpoth, T. Amport, and R. Schmid Hemofiltration during cardiopulmonary bypass: quality assessment of hemoconcentrated blood Thorac Cardiovasc Surg 42 1994 162 169 (Pubitemid 24214405)
349. G.A. Van Norman, M.A. Patel, W. Chandler, and C. Vocelka Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass J Cardiothorac Vasc Anesth 14 2000 253 256 (Pubitemid 30415920)
350. R.A. Kuntz, D.W. Holt, S. Turner, L. Stichka, and B. Thacker Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures J Extracorpor Technol 38 2006 144 153 (Pubitemid 351506599)
351. R.M. Babka, J. Petress, R. Briggs, R. Helsal, and J. Mack Conventional haemofiltration during routine coronary bypass surgery Perfusion 12 1997 187 192 (Pubitemid 27259481)
352. T. Tirilomis, M. Friedrich, H. Sirbu, I. Aleksic, and T. Busch Intraoperative hemofiltration in adults: prevention of hypercirculatory syndrome? Asian Cardiovasc Thorac Ann 13 2005 17 19 (Pubitemid 40613199)
353. J.S. Raman, M. Hata, and R. Bellomo Hemofiltration during cardiopulmonary bypass for high risk adult cardiac surgery Int J Artif Organs 26 2003 753 757 (Pubitemid 37236034)
354. M. Zahoor, S. Abbass, A.A. Khan, and S.A. Ahmad Modified ultrafiltration: role in adult cardiac surgical haemostasis J Ayub Med Coll Abbottabad 19 2007 49 54
355. G.B. Luciani, T. Menon, B. Vecchi, S. Auriemma, and A. Mazzucco Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial Circulation 104 2001 I253 I259
356. R.D. Tallman, M. Dumond, and D. Brown Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass Perfusion 17 2002 111 115 (Pubitemid 34266076)
357. P. Tassani, J.A. Richter, and G.P. Eising Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting J Cardiothorac Vasc Anesth 13 1999 285 291 (Pubitemid 29283379)
358. H. Sirbu, T. Busch, W. Buhre, R.D. Hilgers, and R. Autschbach Influence of venous drainage and hemofiltration on hypercirculatory instability after high volume crystalloid cardioplegia during coronary artery bypass surgery J Cardiovasc Surg (Torino) 46 2005 539 549
359. K.S. Scher, and J.A. Coil Effects of oxidized cellulose and microfibrillar collagen on infection Surgery 91 1982 301 304 (Pubitemid 12187254)
360. M. Sirlak, S. Eryilmaz, and L. Yazicioglu Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery J Thorac Cardiovasc Surg 126 2003 666 670 (Pubitemid 37151948)
361. F. Robicsek Microfibrillar collagen hemostat in cardiac surgery J Thorac Cardiovasc Surg 127 2004 1228 (Pubitemid 38451972)
362. T.L. Ortel, M.C. Mercer, E.H. Thames, K.D. Moore, and J.H. Lawson Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin Ann Surg 233 2001 88 96 (Pubitemid 32043608)
363. W.C. Chapman, N. Singla, and Y. Genyk A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis J Am Coll Surg 205 2007 256 265 (Pubitemid 47095423)
364. M.C. Oz, D.M. Cosgrove, and B.R. Badduke Controlled clinical trial of a novel hemostatic agent in cardiac surgery The Fusion Matrix Study Group Ann Thorac Surg 69 2000 1376 1382 (Pubitemid 30434861)
365. G. Nasso, F. Piancone, and R. Bonifazi Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery Ann Thorac Surg 88 2009 1520 1526
366. The CoStasis Multi-center Collaborative Writing Committee A novel collagen-based composite offers effective hemostasis for multiple surgical indications: results of a randomized controlled trial Surgery 129 2001 445 450
367. M. Codispoti, and P.S. Mankad Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial Eur J Cardiothorac Surg 22 2002 200 205 (Pubitemid 34831856)
368. A.B. Lumsden, and E.R. Heyman Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions J Vasc Surg 44 2006 1002 1009
369. M. Glickman, A. Gheissari, S. Money, J. Martin, and J.L. Ballard A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial Arch Surg 137 2002 326 332 (Pubitemid 34207995)
370. J.S. Coselli, J.E. Bavaria, and J. Fehrenbacher Prospective randomized study of a protein-based tissue adhesive used as a hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures J Am Coll Surg 197 2003 243 253 (Pubitemid 36927387)
371. S.A. LeMaire, L.N. Ochoa, and L.D. Conklin Nerve and conduction tissue injury caused by contact with BioGlue J Surg Res 143 2007 286 293 (Pubitemid 350101556)
372. S.A. LeMaire, S.A. Carter, and T. Won The threat of adhesive embolization: BioGlue leaks through needle holes in aortic tissue and prosthetic grafts Ann Thorac Surg 80 2005 106 111 (Pubitemid 40840192)
373. S.A. LeMaire, Z.C. Schmittling, and J.S. Coselli BioGlue surgical adhesive impairs aortic growth and causes anastomotic strictures Ann Thorac Surg 73 2002 1500 1506 (Pubitemid 34596581)
374. T. Kazui, N. Washiyama, and A.H. Bashar Role of biologic glue repair of proximal aortic dissection in the development of early and midterm redissection of the aortic root Ann Thorac Surg 72 2001 509 514 (Pubitemid 32727158)
375. D.L. Ngaage, W.D. Edwards, M.R. Bell, and T.M. Sundt A cautionary note regarding long-term sequelae of biologic glue J Thorac Cardiovasc Surg 129 2005 937 938 (Pubitemid 40487902)
376. R. Gu, W. Sun, and H. Zhou The performance of a fly-larva shell-derived chitosan sponge as an absorbable surgical hemostatic agent Biomaterials 31 2009 1270 1277
377. H. Xie, J.S. Teach, and A.P. Burke Laparoscopic repair of inferior vena caval injury using a chitosan-based hemostatic dressing Am J Surg 197 2009 510 514
378. R.W. Millner, A.S. Lockhart, H. Bird, and C. Alexiou A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery Ann Thorac Surg 87 2009 e13 e14
379. J.H. Chung, N. Gikakis, and A.K. Rao Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass Circulation 93 1996 2014 2018 (Pubitemid 26165564)
380. T. Hattori, M.M. Khan, R.W. Colman, and L.H. Edmunds Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds J Am Coll Cardiol 46 2005 707 713 (Pubitemid 41132702)
381. L.H. Edmunds The blood-surface interface G.P. Gravlee, R.F. Davis, A.H. Stammers, R. Ungerleider, Cardiopulmonary bypass: principles and practice 3rd ed. 2008 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia 423 438
382. R.C. Gorman, N. Ziats, and A.K. Rao Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass J Thorac Cardiovasc Surg 111 1996 1 12 (Pubitemid 26035166)
383. D. Collen, H.R. Lijnen, and M. Verstraete Synthetic substrates in clinical blood coagulation assays 1980 Martinus Nijhoff Boston ix
384. N.A. Booth, and F. Bachman Plasminogen-plasmin system R.W. Colman, V.J. Marder, A. Clowes, J. George, S. Goldharber, Hemostasis and thrombosis: basic principles and clinical practice 5th ed. 2006 Lippincott Williams & Wilkins Philadelphia 335 364
385. N. Tabuchi, J. de Haan, P.W. Boonstra, and W. van Oeveren Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass J Thorac Cardiovasc Surg 106 1993 828 833 (Pubitemid 23335811)
386. J. de Haan, J. Schonberger, J. Haan, W. van Oeveren, and A. Eijgelaar Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass J Thorac Cardiovasc Surg 106 1993 1017 1023 (Pubitemid 24018543)
387. H. Tatar, S. Cicek, and U. Demirkilic Topical use of aprotinin in open heart operations Ann Thorac Surg 55 1993 659 661 (Pubitemid 23111890)
388. M. De Bonis, F. Cavaliere, and F. Alessandrini Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study J Thorac Cardiovasc Surg 119 2000 575 580 (Pubitemid 30146538)
389. A. Abrishami, F. Chung, and J. Wong Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis Can J Anaesth 56 2009 202 212
390. M.A. Rogers, N. Blumberg, S. Saint, K.M. Langa, and B.K. Nallamothu Hospital variation in transfusion and infection after cardiac surgery: a cohort study BMC Med 7 2009 37
391. F.W. Maddux, T.A. Dickinson, and D. Rilla Institutional variability of intraoperative red blood cell utilization in coronary artery bypass graft surgery Am J Med Qual 24 2009 403 411
392. H. Gombotz, P.H. Rehak, A. Shander, and A. Hofmann Blood use in elective surgery: the Austrian benchmark study Transfusion 47 2007 1468 1480 (Pubitemid 47101072)
393. A.P. Vlaar, A.L. In der Maur, J.M. Binnekade, M.J. Schultz, and N.P. Juffermans Determinants of transfusion decisions in a mixed medical-surgical intensive care unit: a prospective cohort study Blood Transfus 7 2009 106 110
394. The McDonnell Norms Group Enhancing the use of clinical guidelines: a social norms perspective J Am Coll Surg 202 2006 826 836
395. M.D. Cabana, C.S. Rand, and N.R. Powe Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465 (Pubitemid 29493800)
396. L.T. Goodnough, and A. Shander Blood management Arch Pathol Lab Med 131 2007 695 701 (Pubitemid 46726131)
397. F.A. Wolf, L.W. Way, and L. Stewart The efficacy of medical team training: Improved team performance and decreased operating room delays A detailed analysis of 4,863 cases Surgery 252 2010 477 483
398. J. Brevig, J. McDonald, and E.S. Zelinka Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital Ann Thorac Surg 87 2009 532 539
399. S. Verma, M. Eisses, and M. Richards Blood conservation strategies in pediatric anesthesia Anesthesiol Clin 27 2009 337 351
400. J.J. Francis, C. Stockton, and M.P. Eccles Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour Br J Health Psychol 14 2009 625 646
401. S.M. Reddy, S. Talwar, and D. Velayoudam Multi-modality blood conservation strategy in open-heart surgery: an audit Interact Cardiovasc Thorac Surg 9 2009 480 482
402. M.F. Murphy, J. Staves, and A. Davies How do we approach a major change program using the example of the development, evaluation, and implementation of an electronic transfusion management system Transfusion 49 2009 829 837
403. D.B. Hughes, B.W. Ullery, and P.S. Barie The contemporary approach to the care of Jehovah's witnesses J Trauma 65 2008 237 247
404. B.R. Dandolu, J. Parmet, and A. Isidro Reoperative cardiac surgery in Jehovah's witness patients with patent internal thoracic artery grafts: how far can we push the envelope? Heart Surg Forum 11 2008 E32 E33